{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:41:54Z","timestamp":1761896514602},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3,20]]},"DOI":"10.4103\/0366-6999.201609","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T06:00:48Z","timestamp":1488780048000},"page":"665-668","source":"Crossref","is-referenced-by-count":17,"title":["Triazole Resistance in Aspergillus fumigatus Clinical Isolates Obtained in Nanjing, China"],"prefix":"10.1097","volume":"130","author":[{"given":"Ming","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Lai","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20210129","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1086\/323900","article-title":"The impact of culture isolation of Aspergillus species: A hospital-based survey of aspergillosis","volume":"33","author":"Perfect","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R2-7-20210129","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.4103\/0366-6999.162511","article-title":"Integrated therapy for invasive pulmonary aspergillosis in a patient with asthma and chronic obstructive pulmonary disease overlap syndrome","volume":"128","author":"Shi","year":"2015","journal-title":"Chin Med J"},{"key":"R3-7-20210129","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: Clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R4-7-20210129","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/AAC.41.6.1364","article-title":"Itraconazole resistance in Aspergillus fumigatu s","volume":"41","author":"Denning","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"R5-7-20210129","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jac\/47.3.333","article-title":"Acquired itraconazole resistance in Aspergillus fumigatu s","volume":"47","author":"Dannaoui","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"R6-7-20210129","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure","volume":"15","author":"Howard","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"R7-7-20210129","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ijantimicag.2006.08.017","article-title":"Multi-azole resistance in Aspergillus fumigatus","volume":"28","author":"Howard","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"R8-7-20210129","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1473-3099(09)70265-8","article-title":"Azole resistance in Aspergillus fumigatus: A side-effect of environmental fungicide use?","volume":"9","author":"Verweij","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"R9-7-20210129","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1128\/JCM.43.8.3807-3810.2005","article-title":"In vitro susceptibilities of clinical isolates of Candida species Cryptococcus neoformans and Aspergillus species to itraconazole: Global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methods","volume":"43","author":"Pfaller","year":"2005","journal-title":"J Clin Microbiol"},{"key":"R10-7-20210129","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1128\/JCM.00940-09","article-title":"Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods","volume":"47","author":"Pfaller","year":"2009","journal-title":"J Clin Microbiol"},{"key":"R11-7-20210129","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/AAC.05394-11","article-title":"Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan","volume":"56","author":"Tashiro","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"R12-7-20210129","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1128\/AAC.00185-11","article-title":"Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR\/L98H mutation in the cyp51A gene","volume":"55","author":"Lockhart","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"R13-7-20210129","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1128\/AAC.01599-09","article-title":"Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling","volume":"54","author":"Snelders","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R14-7-20210129","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1128\/AAC.00167-13","article-title":"cyp51A-based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany","volume":"57","author":"Bader","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"R15-7-20210129","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3201\/eid1710.110226","article-title":"Clinical implications of azole resistance in Aspergillus fumigatus, the Netherlands, 2007-2009","volume":"17","author":"van der Linden","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"R16-7-20210129","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1469-0691.2008.02086.x","article-title":"EUCAST technical note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds","volume":"14","author":"Rodriquez-Tudela","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"R17-7-20210129","doi-asserted-by":"crossref","first-page":"E278","DOI":"10.1111\/1469-0691.12148","article-title":"European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST). EUCAST technical note on voriconazole and Aspergillus spp","volume":"19","author":"Hope","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"R18-7-20210129","doi-asserted-by":"crossref","first-page":"E248","DOI":"10.1111\/j.1469-0691.2012.03890.x","article-title":"European Committee on Antimicrobial Susceptibility Testing Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST). EUCAST technical note on Aspergillus and amphotericin B, itraconazole, and posaconazole","volume":"18","author":"Arendrup","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"R19-7-20210129","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1128\/JCM.00213-11","article-title":"Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: A laboratory-based study with focus on Aspergillus fumigatus azole resistance","volume":"49","author":"Mortensen","year":"2011","journal-title":"J Clin Microbiol"},{"key":"R20-7-20210129","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1093\/jac\/dkq279","article-title":"Azole antifungal resistance in Aspergillus fumigatus 2008 and 2009","volume":"65","author":"Bueid","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"R21-7-20210129","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1128\/AAC.02487-12","article-title":"Is azole resistance in Aspergillus fumigatus a problem in Spain?","volume":"57","author":"Escribano","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"R22-7-20210129","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3389\/fmicb.2015.00428","article-title":"Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia","volume":"6","author":"Chowdhary","year":"2015","journal-title":"Front Microbiol"},{"key":"R23-7-20210129","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2217\/fmb.11.118","article-title":"Azole resistance in Aspergillus: A growing public health menace","volume":"6","author":"Denning","year":"2011","journal-title":"Future Microbiol"},{"key":"R24-7-20210129","doi-asserted-by":"crossref","first-page":"e31801","DOI":"10.1371\/journal.pone.0031801","article-title":"Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus","volume":"7","author":"Snelders","year":"2012","journal-title":"Plos One"},{"key":"R25-7-20210129","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2217\/fmb.14.27","article-title":"Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms","volume":"9","author":"Chowdhary","year":"2014","journal-title":"Future Microbiol"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/0366-6999.201609","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T19:42:36Z","timestamp":1623958956000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201703200-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,20]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.4103\/0366-6999.201609","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3,20]]}}}